897196319	897196319	CD	B-NP	O
|	|	NN	I-NP	O
NRH	NRH	NN	I-NP	O
|	|	NN	I-NP	O
28354219	28354219	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
893876	893876	CD	B-NP	O
|	|	CC	I-NP	O
8/16/1992	8/16/1992	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/7/1992	8/7/1992	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/4/1992	2/4/1992	CD	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
CORONARY	CORONARY	NN	B-NP	O
ARTERY	ARTERY	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
,	,	,	O	O
STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
MYOCARDIAL	MYOCARDIAL	NN	I-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NN	B-NP	O
DIAGNOSES	DIAGNOSES	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

STATUS	STATUS	NN	B-NP	O
POST	POST	NN	I-NP	O
ATHERECTOMY	ATHERECTOMY	NN	I-NP	O
COMPLICATED	COMPLICATED	VBD	B-VP	O
BY	BY	NN	B-NP	O
REOCCLUSION	REOCCLUSION	NN	I-NP	O
AND	AND	CC	B-NP	O
MYOCARDIAL	MYOCARDIAL	JJ	I-NP	O
INFARCTION	INFARCTION	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

INSULIN	INSULIN	NNP	B-NP	B-protein
DEPENDENT	DEPENDENT	NNP	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ELEVATED	ELEVATED	VBN	B-NP	O
CHOLESTEROL	CHOLESTEROL	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
59	59	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
female	female	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
who	who	WP	B-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
and	and	CC	O	O
early	early	JJ	B-NP	O
positive	positive	JJ	I-NP	O
ETT	ETT	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
of	of	IN	B-PP	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
cholesterol	cholesterol	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
describes	describe	VBZ	B-VP	O
a	a	DT	B-NP	O
6-month	6-month	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
exertional	exertional	JJ	B-NP	O
angina	angina	NN	I-NP	O
described	describe	VBN	B-VP	O
as	as	IN	B-PP	O
chest	chest	NN	B-NP	O
heaviness	heaviness	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
whenever	whenever	WRB	B-ADVP	O
she	she	PRP	B-NP	O
walked	walk	VBD	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
one	one	CD	I-NP	O
block	block	NN	I-NP	O
or	or	CC	O	O
climbed	climbed	JJ	B-NP	O
stairs	stair	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Garrett	Garrett	NNP	I-NP	O
H	H	NNP	I-NP	O
Lipkind	Lipkind	NNP	I-NP	O
,	,	,	O	O
LMD	LMD	NNP	B-NP	O
at	at	IN	B-PP	O
Skaemp	Skaemp	NNP	B-NP	O
Center	Center	NNP	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ETT	ETT	NN	I-NP	O
on	on	IN	B-PP	O
5/23/92	5/23/92	CD	B-NP	O
,	,	,	O	O
modified	modify	VBN	B-VP	O
Bruce	Bruce	NNP	B-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
2	2	CD	B-NP	O
minutes	minute	NNS	I-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
seconds	second	NNS	I-NP	O
,	,	,	O	O
stopped	stop	VBD	B-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
typical	typical	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
135	135	CD	B-NP	O
,	,	,	O	O
83	83	CD	B-NP	O
%	%	NN	I-NP	O
predicted	predict	VBN	B-VP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
20	20	CD	B-NP	O
mm	mm	NN	I-NP	O
horizontal	horizontal	JJ	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
V4-5	V4-5	NN	B-NP	B-protein
,	,	,	O	O
1	1	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
in	in	IN	B-PP	O
II	II	CD	B-NP	O
,	,	,	I-NP	O
III	III	CD	I-NP	O
and	and	CC	O	O
F	F	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
referred	refer	VBN	I-VP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
denies	deny	VBZ	B-VP	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
occasoinal	occasoinal	JJ	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Noninsulin	Noninsulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
oral	oral	JJ	B-NP	O
agent	agent	NN	I-NP	O
times	time	NNS	I-NP	O
six	six	CD	I-NP	O
months	month	NNS	I-NP	O
.	.	.	O	O

Asthma	Asthma	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
recent	recent	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Glucotrol	Glucotrol	NN	B-NP	O
7.5	7.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q-day	q-day	NN	I-NP	O
,	,	,	O	O
Mevacor	Mevacor	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Isoril	Isoril	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Propranolol	Propranolol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Nitroglycerin	Nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
?	?	.	O	O

ALLERGY	ALLERGY	NN	B-NP	O
TO	TO	TO	B-PP	O
UNRECALLED	UNRECALLED	VBN	B-NP	O
ANTIBIOTIC	ANTIBIOTIC	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Brother	Brother	NNP	B-NP	O
required	require	VBD	B-VP	O
CABG	CABG	NN	B-NP	B-protein
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
50	50	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
mother	mother	NN	B-NP	O
died	die	VBD	B-VP	O
of	of	IN	B-PP	O
heart	heart	NN	B-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
age	age	NN	B-NP	O
unknown	unknown	JJ	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
140/70	140/70	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
70	70	CD	I-NP	O
.	.	.	O	O

Neck	Neck	NN	B-NP	O
:	:	:	O	O
negative	negative	JJ	B-NP	O
JVD	JVD	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
carotids	carotid	NNS	I-NP	O
,	,	,	O	O
without	without	IN	B-PP	O
bruits	bruit	NNS	B-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Clear	Clear	JJ	B-ADJP	O
to	to	TO	B-PP	O
auscultation	auscultation	NN	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
rhythm	rhythm	NN	B-NP	O
,	,	,	O	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
a	a	DT	B-NP	O
I/IV	I/IV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
heard	hear	VBD	B-VP	O
best	well	RBS	B-ADVP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Plus	Plus	NN	B-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
nontender	nontender	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
+2	+2	CD	B-NP	O
femorals	femoral	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
,	,	,	O	O
positive	positive	JJ	B-NP	B-DNA
left	left	JJ	I-NP	I-DNA
DP	DP	NN	I-NP	I-DNA
,	,	,	O	O
trace	trace	NN	B-NP	O
PT	PT	NN	I-NP	O
,	,	,	O	O
right	right	JJ	B-NP	O
positive	positive	JJ	I-NP	O
2	2	CD	I-NP	O
DP	DP	NN	I-NP	O
and	and	CC	O	O
plus	plus	CC	O	O
2	2	CD	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
BUN/creatinine	BUN/creatinine	NN	B-NP	O
12/1	12/1	CD	I-NP	O
.2	.2	NN	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	B-protein
318	318	CD	I-NP	I-protein
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
42.3	42.3	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
8.38	8.38	CD	B-NP	O
,	,	,	O	O
cholesterol	cholesterol	NN	B-NP	O
222	222	CD	I-NP	O
,	,	,	O	O
triglycerides	triglyceride	VBZ	B-VP	O
173	173	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
on	on	IN	B-PP	O
1/15/92	1/15/92	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
proximal	proximal	JJ	I-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
diagonal	diagonal	JJ	B-NP	O
1	1	CD	I-NP	O
40	40	CD	I-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
anomalous	anomalous	JJ	I-NP	O
posterior	posterior	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
with	with	IN	B-PP	O
luminal	luminal	JJ	B-NP	O
irregularities	irregularity	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
mean	mean	JJ	I-NP	O
RA	RA	NN	I-NP	O
was	be	VBD	B-VP	O
5	5	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
mean	mean	JJ	I-NP	O
capillary	capillary	JJ	I-NP	O
wedge	wedge	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
11	11	CD	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
output	output	NN	I-NP	O
was	be	VBD	B-VP	O
6.2	6.2	CD	B-NP	O
,	,	,	O	O
wifh	wifh	PDT	B-NP	O
an	an	DT	I-NP	O
FCR	FCR	NN	I-NP	B-protein
of	of	IN	B-PP	O
1226	1226	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
athrectomy	athrectomy	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
proximal	proximal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
lesion	lesion	NN	I-NP	O
through	through	IN	B-PP	O
a	a	DT	B-NP	O
10	10	CD	I-NP	O
French	French	JJ	I-NP	O
arterial	arterial	JJ	I-NP	O
sheath	sheath	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
stenosis	stenosis	NN	I-NP	O
was	be	VBD	B-VP	O
reduced	reduce	VBN	I-VP	O
from	from	IN	B-PP	O
an	an	DT	B-NP	O
80	80	CD	I-NP	O
%	%	NN	I-NP	O
to	to	TO	I-NP	O
20	20	CD	I-NP	O
%	%	NN	I-NP	O
residual	residual	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Heparin	Heparin	NN	I-NP	O
was	be	VBD	B-VP	O
shut	shut	VBN	I-VP	O
off	off	RP	B-PRT	O
,	,	,	O	O
and	and	CC	O	O
sheaths	sheath	NNS	B-NP	O
were	be	VBD	B-VP	O
pulled	pull	VBN	I-VP	O
later	later	RB	B-ADVP	O
that	that	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
post	post	JJ	I-NP	O
atherectomy	atherectomy	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
11/12/92	11/12/92	CD	B-NP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
severe	severe	JJ	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
significant	significant	JJ	B-NP	O
flipped	flipped	JJ	I-NP	O
T-waves	T-wave	NNS	I-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
and	and	CC	O	O
F	F	NN	B-NP	O
and	and	CC	O	O
2	2	CD	B-NP	O
mm	mm	NN	I-NP	O
ST	ST	NN	I-NP	O
depressions	depression	NNS	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
and	and	CC	O	O
F	F	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
brought	bring	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
cath	cath	NN	I-NP	O
lab	lab	NN	I-NP	O
on	on	IN	B-PP	O
11/12/92	11/12/92	CD	B-NP	O
where	where	WRB	B-ADVP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
occluded	occlude	VBD	B-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
dilated	dilate	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
30	30	CD	I-NP	O
%	%	NN	I-NP	O
residual	residual	JJ	B-ADJP	O
with	with	IN	B-PP	O
balloon	balloon	NN	B-NP	O
PTCA	PTCA	NN	I-NP	O
.	.	.	O	O

Thrombus	Thrombus	NN	B-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
prior	prior	JJ	I-NP	B-DNA
athrectomy	athrectomy	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Cardiac	Cardiac	NNP	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
PTCA	PTCA	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
proceeded	proceed	VBD	B-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
in	in	RP	B-PRT	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
with	with	IN	B-PP	O
peak	peak	NN	B-NP	O
CPK	CPK	NN	I-NP	O
's	's	POS	B-NP	O
of	of	IN	B-PP	O
1390	1390	CD	B-NP	O
with	with	IN	B-PP	O
MB	MB	NN	B-NP	O
's	's	POS	B-NP	O
of	of	IN	B-PP	O
55	55	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
post	post	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
course	course	NN	I-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
several	several	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
transient	transient	JJ	B-NP	O
chest	chest	NN	I-NP	O
discomfort	discomfort	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
both	both	CC	B-PP	O
by	by	IN	I-PP	O
Mylanta	Mylanta	NN	B-NP	O
and	and	CC	O	O
sublingual	sublingual	JJ	B-NP	O
TNG	TNG	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
episodes	episode	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
compared	compare	VBN	I-VP	O
with	with	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
nor	nor	CC	O	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
recurrent	recurrent	JJ	B-NP	O
dyspepsia	dyspepsia	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
2/9/92	2/9/92	CD	B-NP	O
,	,	,	O	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
post	post	IN	B-PP	O
MI	MI	NN	B-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
modified	modify	VBN	I-NP	O
Bruce	Bruce	NNP	I-NP	O
ETT	ETT	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
went	go	VBD	B-VP	O
9	9	CD	B-NP	O
minutes	minute	NNS	I-NP	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
remained	remain	VBD	B-VP	O
elevated	elevated	JJ	B-ADJP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Glucotrol	Glucotrol	NN	B-NP	O
with	with	IN	B-PP	O
NPH	NPH	NN	B-NP	O
subcu	subcu	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
hope	hope	NN	I-NP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
eventually	eventually	RB	B-ADVP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
stress	stress	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
would	would	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
prior	prior	JJ	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
thus	thus	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Mevacor	Mevacor	NNP	B-NP	O
for	for	IN	B-PP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
10/10/92	10/10/92	CD	B-NP	O
with	with	IN	B-PP	O
followup	followup	NN	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Kneisel	Kneisel	NNP	I-NP	O
in	in	IN	B-PP	O
Frejames	Frejames	NNP	B-NP	O
Ny	Ny	NNP	I-NP	O
`	`	``	O	O
smiss	smiss	VB	B-VP	O
Hospital	Hospital	NNP	B-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
Mevacor	Mevacor	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q-day	q-day	NN	I-NP	O
,	,	,	O	O
Aspirin	Aspirin	NN	B-NP	O
one	one	CD	I-NP	O
p.o.	p.o.	NN	I-NP	O
q-day	q-day	NN	I-NP	O
,	,	,	O	O
Glucotrol	Glucotrol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
Isordil	Isordil	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
26	26	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
subcutaneously	subcutaneously	RB	B-ADVP	O
each	each	DT	B-NP	O
morning	morning	NN	I-NP	O
.	.	.	O	O

GJ201/2130	GJ201/2130	NN	B-NP	O
YONG	YONG	NNP	I-NP	O
S.	S.	NNP	I-NP	O
UGARTE	UGARTE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
VU00	VU00	NNP	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/3/92	7/3/92	CD	B-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
0485	0485	CD	B-NP	O
Report	Report	NNP	I-NP	O
:	:	:	O	O
G1656N3	G1656N3	NN	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/17/92	4/17/92	CD	B-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
ANDREAS	ANDREAS	NNP	B-NP	O
D.	D.	NNP	I-NP	O
DECONTI	DECONTI	NNP	I-NP	O
,	,	,	O	O
M.D	M.D	NNP	B-NP	O
.	.	.	O	O

